FLUDARABINE-BASED COMBINATION CHEMOTHERAPY IN RELAPSED MANTLE CELL LYMPHOMA - THE EXPERIENCE OF A SINGLE CENTER

被引：0
|
作者：
Moita, F. [1 ]
Santos, J. [1 ]
da Silva, M. G. [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0256
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [21] Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study
    Xiao-Xiao Wang
    Yan Gao
    Jie Jin
    Jun-Ning Cao
    Ji-Feng Feng
    Hua-Qing Wang
    Hui-Lai Zhang
    Qing-Qing Cai
    Zhi-Ming Li
    Wen-Qi Jiang
    Hui-Qiang Huang
    Annals of Hematology, 2021, 100 : 2961 - 2968
  • [22] Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study
    Wang, Xiao-Xiao
    Gao, Yan
    Jin, Jie
    Cao, Jun-Ning
    Feng, Ji-Feng
    Wang, Hua-Qing
    Zhang, Hui-Lai
    Cai, Qing-Qing
    Li, Zhi-Ming
    Jiang, Wen-Qi
    Huang, Hui-Qiang
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 2961 - 2968
  • [23] Fludarabine-based regimens as salvage chemotherapy before bone marrow transplantation for relapsed and refractory acute lymphoblastic leukaemia
    Cioch, M
    Jawniak, D
    Manko, J
    Dmoszynska, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S242 - S242
  • [24] Management of Relapsed Mantle Cell Lymphoma
    Cohen, Jonathon B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S98 - S100
  • [25] Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience
    Yaman, Samet
    Candir, Burcu Aslan
    Bozan, Ersin
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S445 - S445
  • [26] Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Experience
    Matar, Charbel
    Ibrahim, Ali
    Alameddine, Raafat
    El Cheikh, Jean
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S310 - S311
  • [27] THE ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE
    Couto, Maria Eduarda
    Pinho, Vaz Carlos
    Bras, Gil
    Leite, Luis
    Ferreira, Rosa
    Roncon, Susana
    Campos, Junior Antonio
    HAEMATOLOGICA, 2020, 105 : 269 - 269
  • [28] Outcomes after salvage allogeneic stem cell transplantation with myeloablative conditioning FBC in patients with relapsed/refractory mantle cell lymphoma: single-center experience
    Aydilek, E.
    Hasenkamp, J.
    Aperdannier, L.
    Maulhardt, M.
    Mazzeo, P.
    Shumilov, E.
    Wulf, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 304 - 305
  • [29] Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
    Alexander D. Heini
    Ulrike Bacher
    Marie-Noëlle Kronig
    Gertrud Wiedemann
    Urban Novak
    Sacha Zeerleder
    Behrouz Mansouri Taleghani
    Michael Daskalakis
    Thomas Pabst
    Bone Marrow Transplantation, 2022, 57 : 1010 - 1012
  • [30] Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
    Heini, Alexander D.
    Bacher, Ulrike
    Kronig, Marie-Noelle
    Wiedemann, Gertrud
    Novak, Urban
    Zeerleder, Sacha
    Mansouri Taleghani, Behrouz
    Daskalakis, Michael
    Pabst, Thomas
    BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1010 - 1012
12345